Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
about
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseMitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation ProductThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionBlood markers of oxidative stress in Alzheimer's diseaseBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicityMitochondrial lipids in neurodegenerationRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Oxidative stress in the progression of Alzheimer disease in the frontal cortex.Chronic vitamin C deficiency promotes redox imbalance in the brain but does not alter sodium-dependent vitamin C transporter 2 expression.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice.Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer diseaseInvolvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Conformational altered p53 as an early marker of oxidative stress in Alzheimer's diseaseHydrogen sulfide in cell survival: a double-edged sword.Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progressionLong-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.Interactions of glutathione transferases with 4-hydroxynonenal.Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.Physiological antioxidative network of the bilirubin system in aging and age-related diseases.Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults.Neuroinflammation and synaptic lossOxidative stress and lipid peroxidation are upstream of amyloid pathology.Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.Redox proteomics in some age-related neurodegenerative disorders or models thereofLoss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles.
P2860
Q26744105-36B97EFA-1294-4CCC-88B1-3E1049AC4CB7Q26767051-63C742A9-1D50-4DF3-A203-B8082213DD3AQ26782039-D199A015-0DD9-40EB-A8BC-CCE47AD090CAQ26827320-158FAFAE-A429-45C4-9A1A-76956CAD2E13Q26865358-953C7C4F-0C5E-44A0-8FF3-CDC35F95679AQ27021625-BA9F3A04-5FF0-4C7A-AB13-6B3D51E85D05Q28394667-00F591DB-1FF3-416E-8843-05335C91BA2AQ28397548-DF3C82CB-25A8-4410-AC3D-ECB5B81D65A7Q30367032-F23B2D8A-25D5-4965-A81A-439813070A3CQ30446460-97292861-D23A-4DAD-A0E5-BE8BDEB548C7Q33494148-669DAE71-55C6-427D-89F7-5147294978F8Q33506441-0EC6434A-AE32-4ACA-B034-BF3B56BD1190Q33639885-AD693481-E8B2-4BD9-A760-4EF2AAA32AF7Q33680790-C61FAD77-D379-4B19-8813-8E5C9EA57FBBQ33702753-CC67E1E7-91C5-40FC-9EB2-0F71CA67450FQ33712475-35708D98-D26D-4EA3-9727-4559E9B880D6Q33833096-CE07AD93-7811-4C43-8316-3C68EF5A3EC0Q33897525-1A1BF940-52A1-41F4-A808-DBECF0E8B4F7Q33915362-E7A01079-E86E-409D-B598-19C9083000B2Q34094516-83BE9DCB-DEE2-482D-BF54-265F9B726F0DQ34126651-C0D5FD14-49F7-403E-B371-8803B4D0BE73Q34235789-57F2460C-FE63-4AC7-A5D7-CC88651DD0B8Q34512386-0E899C48-C01F-4EC4-AF71-5DB8FBAC424EQ34556705-AD41801B-2352-406D-AC6D-C8D497A1C4D6Q34561160-BD7D9EDF-A6FC-4B75-BDF8-63B0EC25FB41Q34570989-30BD6DD1-15C2-4C83-B42C-C28DEBFB0CEBQ35458379-D372A87D-A0A0-42F6-81E9-15382DAE58E8Q35731685-20F900F6-EDA8-4811-B54D-F5494EE5BFB8Q35738877-8CA98975-E119-4A70-A044-2D91DC0B2F4FQ35828459-ED692E2A-300E-4915-A31E-BD50500C5C6EQ35916225-B05040A1-4B23-40B8-A9D9-9A81D0882023Q36026546-9A53DFC7-93D7-4FE7-A7D9-F2C551BA8EDCQ36076365-6E5857C7-2723-4DF2-A468-0AF23E800DA4Q36246699-048CFD1A-1F68-4DCF-B76F-D517AD7C5250Q36340687-DA317D33-BCBE-40DB-8C6D-2E94F11B616CQ36387084-751C006C-D369-41EE-86E6-5061493DB576Q36390685-FA2817EB-50C5-4E80-8CF9-FA4FFD019788Q36525171-442BFE12-D0EE-4052-A3EA-C7AC1E44C745Q36538283-31D02F43-C8AE-4FAF-B163-37B8A8367957Q36629920-548FAC5A-5F40-452F-B1BA-18C365672D16
P2860
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Elevated protein-bound levels ...... ith mild cognitive impairment.
@en
Elevated protein-bound levels ...... ith mild cognitive impairment.
@nl
type
label
Elevated protein-bound levels ...... ith mild cognitive impairment.
@en
Elevated protein-bound levels ...... ith mild cognitive impairment.
@nl
prefLabel
Elevated protein-bound levels ...... ith mild cognitive impairment.
@en
Elevated protein-bound levels ...... ith mild cognitive impairment.
@nl
P2093
P1433
P1476
Elevated protein-bound levels ...... ith mild cognitive impairment.
@en
P2093
Carlo De Marco
Chiara Cini
Marzia Perluigi
Raffaella Coccia
Rukhsana Sultana
Tanea Reed
P304
P356
10.1016/J.NEULET.2005.12.017
P407
P577
2006-01-04T00:00:00Z